Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Microbiota: a key orchestrator of cancer therapy
The microbiota is composed of commensal bacteria and other microorganisms that live on
the epithelial barriers of the host. The commensal microbiota is important for the health and …
the epithelial barriers of the host. The commensal microbiota is important for the health and …
Cisplatin mouse models: treatment, toxicity and translatability
M Perše - Biomedicines, 2021 - mdpi.com
Cisplatin is one of the most widely used chemotherapeutic drugs in the treatment of a wide
range of pediatric and adult malignances. However, it has various side effects which limit its …
range of pediatric and adult malignances. However, it has various side effects which limit its …
Cisplatin‐induced rodent model of kidney injury: characteristics and challenges
M Perše, Ž Večerić-Haler - BioMed research international, 2018 - Wiley Online Library
Cisplatin is an antitumor drug used in the treatment of a wide variety of malignancies.
However, its primary dose‐limiting side effect is kidney injury, which is a major clinical …
However, its primary dose‐limiting side effect is kidney injury, which is a major clinical …
ROS-modulated therapeutic approaches in cancer treatment
Purpose Reactive oxygen species (ROS) are produced in cancer cells as a result of
increased metabolic rate, dysfunction of mitochondria, elevated cell signaling, expression of …
increased metabolic rate, dysfunction of mitochondria, elevated cell signaling, expression of …
Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications
C Guo, G Dong, X Liang, Z Dong - Nature Reviews Nephrology, 2019 - nature.com
Acute kidney injury (AKI) is a major public health concern associated with high morbidity and
mortality. Despite decades of research, the pathogenesis of AKI remains incompletely …
mortality. Despite decades of research, the pathogenesis of AKI remains incompletely …
PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury
Y Wang, C Tang, J Cai, G Chen, D Zhang… - Cell death & …, 2018 - nature.com
Cisplatin is a widely used chemotherapeutic drug with notorious toxicity in the kidneys,
which involves mitochondrial dysfunction and damage in renal tubular cells. Mitophagy is a …
which involves mitochondrial dysfunction and damage in renal tubular cells. Mitophagy is a …
Microbes and cancer
Commensal microorganisms (the microbiota) live on all the surface barriers of our body and
are particularly abundant and diverse in the distal gut. The microbiota and its larger host …
are particularly abundant and diverse in the distal gut. The microbiota and its larger host …
The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity
Acute kidney injury (AKI) following platinum-based chemotherapeutics is a frequently
reported serious side-effect. However, there are no approved biomarkers that can properly …
reported serious side-effect. However, there are no approved biomarkers that can properly …
Sirt3 modulates fatty acid oxidation and attenuates cisplatin‐induced AKI in mice
M Li, C Li, Z Ye, J Huang, Y Li, W Lai… - Journal of cellular …, 2020 - Wiley Online Library
Fatty acid oxidation (FAO) dysfunction is one of the important mechanisms of renal fibrosis.
Sirtuin 3 (Sirt3) has been confirmed to alleviate acute kidney injury (AKI) by improving …
Sirtuin 3 (Sirt3) has been confirmed to alleviate acute kidney injury (AKI) by improving …
Non-coding RNAs in kidney injury and repair
Z Liu, Y Wang, S Shu, J Cai… - American Journal of …, 2019 - journals.physiology.org
Acute kidney injury (AKI) is a major kidney disease featured by a rapid decline of renal
function. Pathologically, AKI is characterized by tubular epithelial cell injury and death …
function. Pathologically, AKI is characterized by tubular epithelial cell injury and death …